Massachusetts Financial Services
AMPH icon

Massachusetts Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Massachusetts Financial Services’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-57,026
Closed -$827K – 852
2017
Q1 		$827K Buy
57,026
+678
+1% +$10.7K ﹤0.01% 771
2016
Q4 		$1.04M Sell
56,348
-3,392
-6% -$66K ﹤0.01% 760
2016
Q3 		$1.13M Buy
59,740
+13,854
+30% +$251K ﹤0.01% 753
2016
Q2 		$740K Sell
45,886
-2,851
-6% -$40.2K ﹤0.01% 756
2016
Q1 		$585K Sell
48,737
-1,900
-4% -$22.4K ﹤0.01% 767
2015
Q4 		$721K Sell
50,637
-450
-0.9% -$5.94K ﹤0.01% 759
2015
Q3 		$597K Buy
+51,087
New +$766K ﹤0.01% 797

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services's AMPH Position: Q2 2017 in Review

Massachusetts Financial Services sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2017, closing a stake of 57,026 shares — an estimated $827K sold.

Massachusetts Financial Services first reported a position in AMPH in Q3 2015 and held it in 7 quarters. The position peaked at $1.13M in Q3 2016. 108 funds tracked by Wall St. Rank hold AMPH as of Q2 2017.

  • Massachusetts Financial Services reported no remaining Amphastar Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Massachusetts Financial Services sold 57,026 Amphastar Pharmaceuticals shares in Q2 2017, an estimated $827K.
  • Massachusetts Financial Services first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 7 quarters.
  • Massachusetts Financial Services's Amphastar Pharmaceuticals position peaked at $1.13M in Q3 2016.
  • 108 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2017.

Based on Massachusetts Financial Services's 13F filing for Q2 2017, filed 14 Aug 2017.